Life Insurance
Consensus Index

AI Consensus Fit Review

New York Life Whole Life Insurance Fit Review for Cash Value Accumulation

New York Life is a strong fit for a buyer who wants permanent coverage and long-term cash value accumulation, provided the buyer accepts agent-led pricing and non-guaranteed dividends.

Research: 2026-09-207 usable platform responsesRead the methodology ↗

Share

Answer Capsule

New York Life is a strong fit for a buyer who wants permanent coverage and long-term cash value accumulation, provided the buyer accepts agent-led pricing and non-guaranteed dividends. Six of the seven platforms named New York Life during the ranking stage, and all seven evaluated it as at least a "good" fit for this use case. The strongest reason to consider it is its participating whole life lineup — Custom Whole Life and Secure Wealth Plus — backed by top-tier financial-strength ratings and a long dividend record. The main limitation is that no public, standardized premium or policy-level internal rate of return exists; every comparison requires a personalized illustration.

Research Snapshot

FieldFinding
Platform mentions in ranking stage6 of 7 platforms named New York Life (anthropic, deepseek, google, kimi, openai, perplexity)
Share of included platform responses85.7%
Average listed rank3.83
Best listed rank2 (deepseek)
Relevant product/model/planCustom Whole Life (including 10-pay/20-pay) and Secure Wealth Plus participating whole life
Overall use-case fitStrong (openai, anthropic, google, grok); Good (deepseek, kimi, perplexity)
Research date2026-09-20

Why New York Life Qualified for This Study

Questions This Section Answers

  • Is New York Life a good choice for Whole Life Insurance for Cash Value Accumulation?
  • Why did AI platforms rank New York Life for whole life cash value accumulation?

New York Life qualified because it was named by six of the seven platforms during ranking discovery and was evaluated by all seven for this specific use case. Its fit ratings were "strong" from openai, anthropic, google, and grok, and "good" from deepseek, kimi, and perplexity. No platform rated it a poor fit.

The company is a mutual insurer owned by policyholders rather than shareholders [1], and it markets participating whole life products explicitly around cash value accumulation [2]. Its financial-strength ratings — A++ from A.M. Best, AAA from Fitch, Aa1 from Moody's, and AA+ from S&P — are reported on its own ratings page [4] and in its 2026 newsroom release [5]. These ratings assess insurer financial strength and claims-paying ability, not policy investment performance or a guarantee of dividends [4].

New York Life also reports the largest U.S. life insurance market share at 7.4% as of 2025 [7], and independent coverage describes it as one of only two U.S. life insurers with top ratings from all four major agencies [8]. This is the consensus index for the broader Whole Life Insurance for Cash Value Accumulation category.

The Product, Model, Plan, or Service Most Relevant to Whole Life Insurance for Cash Value Accumulation

Questions This Section Answers

  • Which New York Life whole life policy is best for cash value accumulation?
  • Is Secure Wealth Plus or Custom Whole Life better for building cash value efficiently?

The most relevant New York Life products for this use case are Custom Whole Life and Secure Wealth Plus, both participating whole life designs. Platforms converged on these two names, though they described them differently.

Custom Whole Life is positioned as permanent coverage with a limited premium-paying period, including examples of 10 or 20 years [9]. Independent review coverage describes it as available as ordinary (premiums to age 100) or limited-pay (10-pay, 20-pay, and similar) [10], and as blendable with paid-up additions to accelerate early cash value while staying below Modified Endowment Contract limits [11]. Google's platform reported that Custom Whole Life allows buyers to "dial in" payment periods up to age 75 [12].

Secure Wealth Plus is positioned for guaranteed accumulation with increased early-year cash value [9]. New York Life states it offers a cash value enhancement credit during the first two policy years [13]. Independent journalism reported it as a 10-year premium-paying whole life policy for ages 0–60 with a $10,000 minimum annual premium [15]. New York Life's own materials state the product is designed with enhanced early cash value accumulation offset by a lower death benefit [18].

Platforms disagreed on which product to lead with. OpenAI, deepseek, grok, and perplexity named both. Kimi added the Paid-Up Additions Rider as a third relevant component [21]. Buyers should treat product availability as state- and underwriting-dependent; multiple platforms flagged that Secure Wealth Plus state availability and exact mechanics are not fully confirmed from public sources [22].

What the AI Platforms Agreed About

Questions This Section Answers

  • What do AI platforms agree on about New York Life whole life cash value accumulation?
  • Does New York Life offer guaranteed cash value growth plus dividend potential?

Agreement was strong, though not unanimous, on four points.

Guaranteed cash value growth. New York Life states that whole life cash value is guaranteed to grow over time and accumulates tax-deferred, subject to the policy contract and continued premium compliance [24]. The company also states all whole life policies offer a guaranteed death benefit and cash value growth, though the amount varies by policy [25]. Independent review coverage states cash value grows tax-deferred under IRC 7702 [26].

Dividend participation with a long track record. New York Life has paid participating dividends for 172 consecutive years since 1854 [27], and announced a record $2.78 billion dividend payout for 2026, described as the largest in its 180-year history [28]. Independent review coverage cites a 6.40% dividend interest rate applied for 2026 [30]. New York Life states dividends are not guaranteed and depend on the applicable dividend scale and company experience [32].

Carrier financial strength. New York Life reports current ratings of A++ (A.M. Best), AAA (Fitch), Aa1 (Moody's), and AA+ (S&P) [33]. Independent journalism reported the same four-agency top-tier position [35].

Cash value access via loans or withdrawals. New York Life states cash value can be accessed through loans or withdrawals/surrenders [36], and that loans and surrenders reduce cash value and death benefit by the outstanding loan amount and accrued interest [37]. Several platforms noted New York Life uses non-direct recognition, meaning outstanding policy loans do not reduce dividend eligibility [38].

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

  • How competitive is New York Life's early cash value growth compared with other mutual insurers?
  • Are New York Life's paid-up additions rules flexible enough for aggressive cash value funding?

Platforms disagreed on early cash value competitiveness and on paid-up additions flexibility.

Early cash value competitiveness. Kimi reported that in head-to-head illustrations, Penn Mutual's Accumulation Whole Life often produces higher actual cash value by years 5–10 despite a lower stated dividend rate, and that independent comparisons of Secure Wealth Plus are less favorable [41]. Perplexity stated New York Life is "not the strongest fit for buyers seeking the most aggressive early cash value" and that public sources do not provide a full apples-to-apples internal rate of return comparison [43]. OpenAI and google, by contrast, treated Secure Wealth Plus's early cash value design as a clear advantage [44]. This is a genuine conflict, not a consensus.

Paid-up additions flexibility. Kimi reported New York Life's paid-up additions rider has no catch-up provision and is among the most restrictive in the industry [42]. Google's platform reported the opposite — a highly flexible rider with a low minimum ($10 monthly or $120 annually) and high maximum annual payment limits [46]. Both are platform-reported and neither was independently verified here. Buyers should confirm rider terms in the actual contract.

Moody's rating conflict. New York Life's current ratings page reports Moody's Aa1, while an older company document reports Moody's Aaa [47]. The current rating page and latest dated company materials should control, and the buyer should verify ratings directly with the agencies.

Pricing opacity. Every platform flagged that no public, standardized premium quote exists. Deepseek noted no public pricing data was found to verify premium levels [48]. Perplexity rated pricing confidence "moderate" because a published charges document exists [49], while openai, anthropic, deepseek, grok, and kimi all rated pricing confidence "low."

Use-Case-Specific Features and Capabilities

Questions This Section Answers

  • What features make New York Life whole life suitable for long-term cash value accumulation?
  • How does New York Life's non-direct recognition loan feature affect cash value growth?

The features most relevant to cash value accumulation are limited-pay design, early cash value enhancement, dividend participation, and loan treatment.

Limited-pay design. Custom Whole Life permits a limited premium-paying period, including examples of 10 or 20 years [50]. Independent review coverage describes ordinary and limited-pay configurations [51].

Early cash value enhancement. Secure Wealth Plus is specifically marketed as increasing guaranteed cash value during the early years of coverage [50]. New York Life states a cash value enhancement credit applies during the first two policy years [53]. The trade-off is explicit: enhanced early cash value is generally offset by a lower insurance amount [55].

Dividend participation. Eligible participating policies may receive dividends, which can be used to purchase paid-up additions to increase cash value and death benefit [57]. Dividends can also offset premium costs [58]. Dividends are not guaranteed [59].

Loan treatment. New York Life uses non-direct recognition, meaning outstanding policy loans do not reduce dividend eligibility [60]. Loans accrue interest daily and reduce cash surrender value and death benefit until repaid [62].

Tax treatment. Cash value grows tax-deferred under IRC 7702 [64], and policy loans can be accessed on a tax-free basis [65]. These outcomes are conditional and not guaranteed in general public materials [66].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

  • How much does New York Life whole life cost per month, and are there setup or cancellation fees?
  • What charges apply to New York Life paid-up additions and policy loans?

No reliable universal premium price was found. New York Life whole life pricing is individualized by age, sex, health, underwriting class, face amount, riders, premium duration, payment mode, state, and policy design [67]. A policy-specific illustration is required to compare guaranteed and non-guaranteed values.

Known and disclosed costs, drawn from platform-reported sources:

  • Policy fee: $55–$100, per a published charges document [69].
  • Non-annual payment mode factors: increase annualized cost; a policy fee up to an annualized cap not exceeding $216 applies for non-annual modes [69].
  • Paid-up additions premium expense charge: 5% to 35% of the additional premium may be deducted before the remainder is applied to the policy, per New York Life's disclosed charge range [70].
  • Loan interest: accrues daily at the greater of 5% or the Moody's Corporate Bond Yield Average – Monthly Corporate Averages [69].
  • Living-benefits rider fee: a possible one-time $100 fee, up to a maximum of $150, when that rider is exercised [70].
  • Secure Wealth Plus minimum annual premium: $10,000 [71].
  • Custom Whole Life minimum face amount: $50,000, per grok's platform report [74].

Contract terms: early surrender can result in surrender charges and materially lower proceeds [75]. Policy loans and accrued interest reduce cash surrender value and death benefit and can create lapse or tax risks if the policy becomes underfunded [75]. Nonforfeiture options may apply if premiums stop, but resulting coverage or cash value may differ substantially from the original design [75]. Whole life premiums are guaranteed level and never increase [76]. 10-pay and 20-pay availability, minimum premiums, rider availability, and state-specific terms must be verified for the buyer's state [75].

Best Suited For

Questions This Section Answers

  • Who is New York Life whole life best suited for in a cash value accumulation strategy?
  • Is New York Life a good fit for a buyer who wants limited-pay whole life with dividends?

New York Life is best suited for buyers who will hold coverage long term and pay higher premiums than term insurance [77]. The strongest-fit profiles across platforms:

  • Buyers seeking guaranteed cash-value growth plus possible participating-policy dividends [77].
  • Buyers who value a financially strong mutual insurer and may prefer limited-pay designs such as 10-pay or 20-pay where available [77].
  • Buyers who want policy loans or withdrawals as a source of liquidity while retaining permanent coverage [77].
  • High-net-worth individuals and business owners needing permanent protection with significant cash value accumulation and dividend participation [80].
  • Buyers who value non-direct recognition policy loans for uninterrupted dividend earnings [81].
  • Buyers who can meet the $10,000 minimum annual premium for Secure Wealth Plus and fall within ages 0–60 [83].

Probably Not Best Suited For

Questions This Section Answers

  • Who should not choose New York Life for Whole Life Insurance for Cash Value Accumulation?
  • Is New York Life a poor fit for buyers who need low-cost death benefit protection?

New York Life is probably not the best fit for several buyer profiles, and platforms were consistent on this.

  • Buyers seeking the lowest-cost death benefit [85].
  • Buyers who may surrender the policy early [85].
  • Buyers seeking fully transparent, directly published online pricing before underwriting [85].
  • Buyers whose primary objective is investment return rather than permanent insurance [85].
  • Buyers needing maximum death benefit relative to premium, since Secure Wealth Plus sacrifices benefit for early cash value by design [91].
  • Buyers with annual premium budgets below $10,000 who want the accumulation-focused Secure Wealth Plus design [93].
  • Buyers over age 60 for Secure Wealth Plus, who would need Custom Whole Life or standard whole life instead [93].
  • Buyers who want frequent policy adjustments or maximum premium flexibility, since whole life has fixed premiums and structured design [94].

When Another Option May Be Better

Questions This Section Answers

  • What is a better alternative to New York Life for a buyer who needs maximum early cash value efficiency?
  • When should a buyer choose a different carrier or product instead of New York Life whole life?

Platforms named several scenarios where another option may serve the buyer better.

Maximum early cash value efficiency. Kimi reported that Penn Mutual's Accumulation Whole Life may outperform in years 1–10 [95]. Perplexity advised choosing another insurer if the buyer wants the most competitive early cash value illustration and lower premium outlay [97].

Flexible paid-up additions with catch-up ability. Kimi reported MassMutual or other mutuals with less restrictive riders may fit better [96].

Lowest premium per dollar of death benefit. OpenAI, deepseek, and perplexity all advised comparing competitively priced term insurance or non-participating whole life if the priority is cheap protection rather than accumulation [98].

Investment flexibility with market risk. OpenAI advised comparing diversified investment strategies separately from insurance, and comparing properly designed universal-life alternatives, including indexed or variable products, with careful attention to costs and lapse risk [98]. Anthropic noted New York Life's own Market Wealth Plus (variable universal life) offers equity market exposure [100].

Guaranteed accumulation without a death benefit. OpenAI advised comparing appropriate fixed annuity alternatives, recognizing they serve a different purpose [98].

Online-first, agent-free shopping. Multiple platforms noted New York Life sells almost entirely through captive agents with no online quotes [101]. Buyers who require digital comparison should look at carriers with multi-carrier quoting or direct writers.

Questions to Verify Before Buying

Questions This Section Answers

  • What should a buyer confirm with New York Life before signing a whole life contract?
  • How can a buyer verify New York Life's guaranteed versus non-guaranteed cash value projections?

Platforms supplied overlapping verification lists. The consolidated set:

  1. What are the guaranteed cash values, surrender values, death benefits, and premiums at each year through at least years 5, 10, 20, and life expectancy? [105]
  2. What is the guaranteed versus non-guaranteed portion of every illustrated value? [105]
  3. What dividend scale, dividend interest assumptions, and dividend options are being used, and what happens if dividends are reduced or eliminated? [105]
  4. What is the policy's break-even year on guaranteed and current-assumption bases? [105]
  5. What are the exact surrender charges and nonforfeiture values by policy year? [105]
  6. What are the loan interest rate, loan-crediting treatment, direct versus non-direct recognition treatment, and lapse consequences? [105]
  7. What percentage of paid-up-additions premiums is deducted as an expense charge for this exact policy and rider? [105]
  8. Are 10-pay, 20-pay, or other limited-pay configurations available in the buyer's state and at the proposed issue age? [105]
  9. Is Secure Wealth Plus available in the buyer's state and age band? [107]
  10. What is the minimum death benefit, and how much does early cash value design reduce it versus standard whole life? [107]
  11. What happens if a premium is missed, reduced, or paid late? [105]
  12. Will a proposed withdrawal or loan affect the death benefit, dividend eligibility, tax treatment, or policy guarantee? [105]
  13. Can the buyer obtain the full policy contract, current illustration, guaranteed ledger, and a competing carrier illustration before purchase? [105]
  14. How does the historical dividend performance of New York Life compare to other major mutual carriers under the buyer's specific illustrated design? [109]
  15. How is the policy structured to avoid becoming a Modified Endowment Contract if the buyer maximizes paid-up additions contributions? [110]

Final AI Consensus Verdict

New York Life is a strong fit for Whole life insurance for Cash Value Accumulation, with important qualifications. Six of seven platforms named it during ranking discovery, and all seven rated it at least a "good" fit. The strongest reasons are its participating whole life lineup — Custom Whole Life and Secure Wealth Plus — its top-tier financial-strength ratings, its 172-year dividend record, and its non-direct recognition loan treatment. The main limitations are the absence of public standardized pricing, non-guaranteed dividends, a lower death benefit in the accumulation-focused design, a $10,000 minimum annual premium for Secure Wealth Plus, and platform disagreement about whether its early cash value growth is competitive with other mutual insurers. Buyers should select only after comparing policy-specific guaranteed ledgers, current-assumption illustrations, surrender schedules, rider charges, and loan provisions against multiple competing mutual insurers. AI-platform agreement does not prove product quality; it reflects what these platforms reported.

How This Review Was Produced

This review was produced from seven AI-platform responses to a single prompt asking which whole life insurance carriers they would recommend for a consumer prioritizing long-term cash value accumulation, a meaningful death benefit, a financially established carrier, strong guaranteed policy values, competitive non-guaranteed potential, and flexible access to accumulated cash value. The research date is 2026-09-20. Six of the seven platforms named New York Life during ranking discovery; all seven evaluated it for fit. Platform fit ratings were: strong (openai, anthropic, google, grok) and good (deepseek, kimi, perplexity). Citations are platform-reported evidence, not independently verified facts. Company-owned citations materially outnumber independent citations in the supplied source set, so company claims should not be described as independently verified. The supplied URLs were collected from platform responses and were not independently validated by the writer stage. This report evaluates New York Life only for Whole Life Insurance for Cash Value Accumulation; it is not a broad company review. Related coverage is organized in the life insurance category directory.

Methodology Limitations

  • Platform-reported research dates differ from the authoritative run date of 2026-09-20. Deepseek reported 2026-01-22; the other six platforms reported 2026-09-21. These are provenance metadata and do not independently prove freshness.
  • All included platforms evaluated fit, but platform_mentions counts only platforms that named the entity during ranking discovery.
  • Conflicting product names, pricing, and capabilities were not resolved by guessing; conflicts are described and buyers are told what to verify.
  • The supplied URLs were collected from platform responses and were not independently validated by the writer stage.
  • Company-owned citations materially outnumber independent citations; company claims are not independently verified.
  • Citations are platform-reported evidence, not independently verified facts. No-search model claims require explicit verification before being described as current facts. Deepseek's response was produced with search disabled.
  • No public, standardized premium quote or policy-specific internal rate of return comparison is available without underwriting and an illustration.
  • Dividends are non-guaranteed and should not be treated as guaranteed accumulation.
  • AI-platform agreement does not prove product quality.

Sources

Company-Owned Sources

Independent Sources

Other Sources

  • What is cash value and how does it differ from the face amount? - NY DFS: https://www.dfs.ny.gov/faqs/consumer-life/what-cash-value-and-how-does-it-differ-face-amount-whole-life-policy
  • Additional AI research evidence110 records
    1. AI research evidence record anthropic:c29
    2. AI research evidence record openai:c1
    3. AI research evidence record deepseek:c2
    4. AI research evidence record openai:c4
    5. AI research evidence record anthropic:c2
    6. AI research evidence record anthropic:c4
    7. AI research evidence record anthropic:c1
    8. AI research evidence record anthropic:c3
    9. AI research evidence record openai:c1
    10. AI research evidence record anthropic:c12
    11. AI research evidence record anthropic:c13
    12. AI research evidence record google:cit_monegenix_top5
    13. AI research evidence record anthropic:c6
    14. AI research evidence record google:cit_nyl_secure_wealth_plus
    15. AI research evidence record anthropic:c11
    16. AI research evidence record anthropic:c24
    17. AI research evidence record google:cit_nyl_launch_wealth_plus
    18. AI research evidence record anthropic:c16
    19. AI research evidence record anthropic:c22
    20. AI research evidence record perplexity:c4
    21. AI research evidence record kimi:newyorklife-products
    22. AI research evidence record deepseek:c2
    23. AI research evidence record perplexity:c3
    24. AI research evidence record openai:c1
    25. AI research evidence record perplexity:c11
    26. AI research evidence record anthropic:c30
    27. AI research evidence record anthropic:c8
    28. AI research evidence record anthropic:c9
    29. AI research evidence record google:cit_nyl_dividend_2026
    30. AI research evidence record anthropic:c7
    31. AI research evidence record google:cit_topwholelife_dividend_2026
    32. AI research evidence record openai:c2
    33. AI research evidence record openai:c4
    34. AI research evidence record anthropic:c4
    35. AI research evidence record anthropic:c3
    36. AI research evidence record perplexity:c1
    37. AI research evidence record perplexity:c12
    38. AI research evidence record anthropic:c15
    39. AI research evidence record kimi:rateschaser-2026
    40. AI research evidence record google:cit_monegenix_top5
    41. AI research evidence record kimi:insuranceandestates-2026
    42. AI research evidence record kimi:betterwealth-2026
    43. AI research evidence record perplexity:c3
    44. AI research evidence record openai:c1
    45. AI research evidence record google:cit_nyl_secure_wealth_plus
    46. AI research evidence record google:cit_monegenix_top5
    47. AI research evidence record openai:c5
    48. AI research evidence record deepseek:c2
    49. AI research evidence record perplexity:c6
    50. AI research evidence record openai:c1
    51. AI research evidence record anthropic:c12
    52. AI research evidence record anthropic:c5
    53. AI research evidence record anthropic:c6
    54. AI research evidence record google:cit_nyl_secure_wealth_plus
    55. AI research evidence record anthropic:c16
    56. AI research evidence record anthropic:c22
    57. AI research evidence record anthropic:c10
    58. AI research evidence record anthropic:c26
    59. AI research evidence record openai:c2
    60. AI research evidence record anthropic:c15
    61. AI research evidence record kimi:rateschaser-2026
    62. AI research evidence record anthropic:c14
    63. AI research evidence record perplexity:c12
    64. AI research evidence record anthropic:c30
    65. AI research evidence record anthropic:c31
    66. AI research evidence record perplexity:c3
    67. AI research evidence record openai:c1
    68. AI research evidence record deepseek:c2
    69. AI research evidence record perplexity:c6
    70. AI research evidence record openai:c6
    71. AI research evidence record anthropic:c11
    72. AI research evidence record anthropic:c24
    73. AI research evidence record google:cit_nyl_launch_wealth_plus
    74. AI research evidence record grok:0
    75. AI research evidence record openai:c3
    76. AI research evidence record anthropic:c25
    77. AI research evidence record openai:c1
    78. AI research evidence record anthropic:c12
    79. AI research evidence record perplexity:c1
    80. AI research evidence record anthropic:c1
    81. AI research evidence record kimi:rateschaser-2026
    82. AI research evidence record google:cit_monegenix_top5
    83. AI research evidence record anthropic:c11
    84. AI research evidence record anthropic:c24
    85. AI research evidence record openai:c1
    86. AI research evidence record deepseek:c2
    87. AI research evidence record openai:c3
    88. AI research evidence record anthropic:c20
    89. AI research evidence record anthropic:c21
    90. AI research evidence record google:cit_insurify_top10
    91. AI research evidence record anthropic:c16
    92. AI research evidence record anthropic:c22
    93. AI research evidence record anthropic:c24
    94. AI research evidence record anthropic:c25
    95. AI research evidence record kimi:insuranceandestates-2026
    96. AI research evidence record kimi:betterwealth-2026
    97. AI research evidence record perplexity:c3
    98. AI research evidence record openai:c1
    99. AI research evidence record deepseek:c2
    100. AI research evidence record anthropic:c1
    101. AI research evidence record anthropic:c20
    102. AI research evidence record anthropic:c21
    103. AI research evidence record kimi:rateschaser-2026
    104. AI research evidence record google:cit_insurify_top10
    105. AI research evidence record openai:c1
    106. AI research evidence record anthropic:c1
    107. AI research evidence record perplexity:c3
    108. AI research evidence record deepseek:c2
    109. AI research evidence record google:cit_nyl_whole_life_overview
    110. AI research evidence record google:cit_nyl_worth_it

Verify this research

Check when the research was run, which platforms were included, and what supports the findings.

Study date
September 20, 2026
Platforms analyzed
7
Source records
42
Ranking mentions
6 of 7
Platform share
86%
Final consensus rank
#3

Behind the findings

Platforms in this study

  • ChatGPT
  • Claude
  • DeepSeek
  • Grok
  • Perplexity
  • Kimi
  • Gemini

Source records

17 independent · 22 company-owned · 3 unclear

Evidence support

35 direct · 7 partial

Keep in mind

Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.

Technical verification details

Use this SHA-256 fingerprint to identify the source snapshot associated with this study.

735bf6de533b641ed2e5cf1c212d10d262def2213c281de65caa1a731d3f5974